Abstract
Complete remission from recurrent EBV-positive lymphoma is not mandatory before HSCT to achieve long-term cure in a patient suffering from a recently described immunodeficiency affecting the T-cell coactivation molecule 4-1BB.
- Title
- Successful hematopoietic stem cell transplantation in a 4-1BB deficient patient with EBV-induced lymphoproliferation
- Creators - without role
- Christine Wildermann - College Station Medical CenterMohammed Alosaimi - Boston Children's HospitalSophie Liebenehm - College Station Medical CenterEva-Maria Jacobsen - College Station Medical CenterThomas F. E. Barth - College Station Medical CenterPeter Moeller - College Station Medical CenterKlaus-Michael Debatin - College Station Medical CenterAnsgar Schulz - College Station Medical CenterMehtap Sirin - College Station Medical CenterIbraheem F. Abosoudah - King Faisal Specialist Hospital & Research CentreFowzan S. Alkuraya - King Faisal Specialist Hospital & Research CentreRaif S. Geha - Boston Children's HospitalManfred Hoenig - College Station Medical Center
- Publication Details
- Clinical immunology (Orlando, Fla.), Vol.222, pp.108639-108639
- Publisher
- Elsevier
- Number of pages
- 3
- Grant note
- 1R01AI139633-01 / Perkin Fund
- Identifiers
- 9946027708331
- Academic Unit
- King Saud University
- Language
- English
- Resource Type
- Journal article